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ABSTRACT
Many bacterial genes are controlled by metabolite
sensing motifs known as riboswitches, normally
located in the 50 un-translated region of their
mRNAs. Small molecular metabolites bind to the
aptamer domain of riboswitches with amazing
specificity, modulating gene regulation in a
feedback loop as a result of induced conformational
changes in the expression platform. Here, we
report the results of molecular dynamics simulation
studies of the S-adenosylmethionine (SAM)-II
riboswitch that is involved in regulating translation
in sulfur metabolic pathways in bacteria. We show
that the ensemble of conformations of the unbound
form of the SAM-II riboswitch is a loose pseudoknot
structure that periodically visits conformations
similar to the bound form, and the pseudoknot
structure is only fully formed upon binding the
metabolite, SAM. The rate of forming contacts in
the unbound form that are similar to that in the
bound form is fast. Ligand binding to SAM-II alters
the curvature and base-pairing of the expression
platform that could affect the interaction of the
latter with the ribosome.
INTRODUCTION
Antibiotic resistance is viewed as one of the most pressing
public health problems around the world. According to
the US Food and Drug Administration, the need for
new antibiotics is imperative to the successful treatment
of new resistant bacterial infections (1). Several major
diseases caused by microbes, such as Tuberculosis, are
becoming increasingly more diﬃcult to treat with
commonly used drugs. The excess use of antibiotics and
evolutionary adaptations of bacteria have exacerbated this
problem. The need to develop new antimicrobial drugs is
of the utmost importance, and a greater understanding of
bacterial gene regulation is a key to solving this problem.
One possible drug target for the new class of antibiotics
is the recently discovered metabolite sensing domain of
bacterial mRNA (2–5). About 4% of all bacterial genes
are regulated at the post-transcriptional level by small
metabolites binding to mRNAs (6–9). These transcribed
mRNAs typically have a ligand-binding ‘aptamer’
domain and an ‘expression platform’ located in the 50
un-translated region (UTR). The binding of cognate
metabolites, which are generally synthesized by the
proteins of the respective mRNAs, to the aptamer
triggers conformational changes in the expression plat-
forms resulting in initiation or termination of either tran-
scription or translation. The structured 50 UTR, known as
a ‘riboswitch’, eﬀectively functions as an environmentally
sensitive switch capable of sensing local cellular concen-
trations of metabolites or other ligands in a feedback loop.
At the level of translation, riboswitches act by exposing or
obscuring the Shine–Dalgarno (SD) sequence and the ini-
tiation codon, which are vital elements in ribosomal
binding and processing of mRNAs (10). When the bases
in the expression platform are hidden, the ribosome
cannot bind to the mRNA or initiate translation (11,12).
When they are exposed, the ribosome can bind and initiate
or resume translation.
Many riboswitches that regulate a host of biosynthetic
pathways have been discovered (13). The metabolites they
bind include glycine (14), lysine (15–17), adenine (18,19),
guanine (20,21), 7-aminomethyl-7-deazaguanine (22,23),
thiamine pyrophosphate (8,24–27), ﬂavin mononucleotide
(28,29), vitamin B12 (30,31), glucosamine-6-phosphate
(32–35), and S-adenosylmethionine (SAM) (36,37). SAM
is a co-factor involved in the ubiquitous methionine bio-
synthesis and related sulfur metabolic pathways in all
bacteria (36). Interestingly, the overall fold of the SAM
sensing riboswitch is diﬀerent in diﬀerent types of
bacteria. Five diﬀerent folds of SAM riboswitches have
been discovered to date, vis-a ` -vis, SAM-I (36,38),
SAM-II (39,40), SAM-III (41), SAM-IV (42) and
SAM-V (43,44). Of these riboswitches, SAM-I and
SAM-IV share similar binding pockets and signiﬁcant
structural elements (42), and SAM-V appears to share
similar core structure to SAM-II (13). SAM-II riboswitch
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SAM (10). SAM-II riboswitch binds SAH (S-adenosylho-
mocysteine) and other similar byproducts of SAM with
much lower aﬃnity (40). The speciﬁcity of SAM-II for
SAM and the fact that the X-ray crystal structure of
SAM-II is one of the only riboswitches containing all of
the sequence of the ligand-binding domain and the regu-
latory expression platform make SAM-II an excellent
model system to study (10).
Furthermore, the crystal structure of the SAM-II
metabolite-bound riboswitch, solved by Gilbert et al.
(10), is a classic H-type pseudoknot shown in Figure 1
(45), a motif that is widespread in RNA biology. The reg-
ulatory expression platform (and the SD sequence) is part
of the purine-rich region (Figure 1; orange). L1 (green in
Figure 1A) interacts with the major groove of the P2a/b
helix in a triple helical structure that is characteristic of
pseudoknot structures. The expression platform that is in
the 30-end of P2a/b follows the curvature of the helix and
forms base-pairing with the 50-end of P2a/b in the crystal
structure of the metabolite-bound riboswitch. The nature
of the unbound state of the SAM-II riboswitch at the
atomistic detail is not known. However, the response of
diﬀerent regions of the SAM-II riboswitch to ligand
binding has been extensively studied using chemical and
inline probing experiments (10,39). Ligand-dependent sta-
bilization of L1 and the P2a/b helix were observed in the
chemical probing experiments. On the other hand, the P1
helix was predominately unchanged upon ligand binding.
SAM binds in the groove between L1 and the 50-end of
the P2 helix of the SAM-II riboswitch. The adenine group
of SAM appears (Figure 1) to mimic a base on the 50-end
of P2 by intercalating and stacking between U21 and G22
and interacting with its Hoogsteen base-pairing face to an
unpaired U44 on the 30-end of P2b, stabilizing the helix
(Figures 1B). U44 then interacts with U10 on L1,
stabilizing the triple helix. The positively charged sulfur
moiety of SAM interacts with the two carbonyl oxygen
groups on U21 from P2b and U11 from L1, further
stabilizing the triple helix between P2a/b and L1, in a
site created by the triple base U11 (U21-A45). This inter-
action site seems to be one of the key components in the
speciﬁcity of the SAM-II riboswitch for SAM, because
SAH, which lacks the single positive charge, binds to
SAM-II with an aﬃnity reduced by at least three orders
of magnitude (40).
Atomic structures of the unbound state of riboswitches
have been solved for only a handful of systems, and these
structures include X-ray crystal structures of the glmS (33)
and lysine (46,47) riboswitches and NMR structure of the
preQ1 (48) riboswitch. NMR studies have also been
carried out on the free and bound forms of the
purine-sensing riboswitch (49–52). Most of the X-ray
crystal structures of riboswitches that undergo large
conformational changes have only been solved in their
metabolite bound form. Therefore, questions do arise
about the nature of their unbound states. For example,
how do riboswitches switch conformations from the oﬀ to
the on state, or vice versa? Direct observations at this level
of detail are not always easy to achieve with current exper-
imental techniques. In this regard, all-atom molecular
dynamics (MD) simulation has proven invaluable as a
complimentary technique to experiments in understanding
biomolecular structures, dynamics and function (53–55).
Figure 1. The classic H-type pseudoknot structure of the SAM-II riboswitch (PDB id 2qwy). L1 (green) is localized in the groove of the P2b helix,
and the expression platform which follows the curvature of the P2a/b helix is part of the purine rich sequence shown in orange (A). SAM (cyan) is
bound in the groove formed by L1 and the 50-end of P2b, and the adenine moiety of SAM mimics a base on the 50-end of P2b by intercalating and
stacking between U21 and G22 (B). The secondary structure of the SAM-II riboswitch is shown (C), with the base pairing interactions represented
using commonly used notations. The other non-standard interactions observed in the X-ray structure that form the remaining tertiary interactions
are not shown. The base-pairing interactions between L1, P2b and SAM in the metabolite bound X-ray crystal structure of the SAM-II
riboswitch are shown in (B). The distances between N3 of U10 and O4 of U44 (black), O4 of U11 and O4 of U21 (red), and O4 of U12 and
N6 of A46 (blue) are used to monitor the interaction of L1 with the major groove of the helix.
Nucleic Acids Research,2010, Vol.38, No. 4 1393This simulation method and related techniques have been
used to study other types of riboswitches and have
provided very useful information about ligand-induced
conformational changes (56–59). We have therefore used
MD simulations to probe the dynamics of the SAM-II
riboswitch in the bound and unbound forms in order to
understand the role of SAM in stabilizing the oﬀ state of
the riboswitch and the nature of the expression platform
in the bound and unbound forms.
RESULTS AND DISCUSSIONS
In order to study the atomistic basis for the switching
mechanism between the on and oﬀ states of the SAM-II
riboswitch, we have carried out two very long all-atom
MD simulations (200ns each) on the bound and
unbound forms in explicit water and ions. The snapshots
of the ﬁrst 50ns of each simulation were discarded in
order to make sure that the systems were well equilibrated.
The trajectories of the last 150ns of each simulation were
analyzed.
Conformational switching of the pseudoknot structure
of the SAM-II riboswitch
There are three major hydrogen bonding and electrostatic
interactions between SAM and the RNA (Figure 1B) that
are intricately involved in stabilizing the pseudoknot
structure. The extended structure of SAM also spans
three of the interactions made by L1 and the major
groove of P2b, as shown in Figure 1B. We have monitored
the three interactions formed by L1 and the major groove
of the P2b helix in the presence and absence of SAM in
order to probe the role of SAM in preserving these inter-
actions and the integrity of the SAM-II pseudoknot struc-
ture. Two of the three interactions L1 makes with the
major groove of the P2b helix that are between N3 of
U10 and O4 of U44 and between O4 of U11 and O4 of
U21 directly involve SAM and are well-formed in the
complex (oﬀ state) throughout the simulation, as shown
in Figure 2 (left column). The distance between O4 of U11
and O4 of U21 is used to monitor the second interaction,
because the proximity of these two atoms is essential to
the formation of the interaction site for the positively
charged sulfur group in SAM. The third interaction
between O4 of U12 and N6 of A46, also shown in
Figure 2 (left column), is quite stable throughout the sim-
ulation with some breathing motions taking place. The
third interaction does not form any hydrogen bonding
interactions with SAM. SAM locks the ﬁrst two interac-
tions in place and stabilizes the pseudoknot structure. The
third interaction seems to naturally follow.
We have studied these same interactions in the unbound
form of the SAM-II riboswitch, also shown in Figure 2
(right column). The interactions behave quite diﬀerently in
the unbound form of the riboswitch. The interactions are
not as stable as they are in the bound form. They form and
break, alternating between diﬀerent states. As a result, L1
moves in and out of the major groove of the P2a/b helix.
One of the states of the unbound form is close to the
conformational state of the bound form, with some of
the key interactions formed, and the other states can be
viewed as a more relaxed and less compact ensemble of
conformations. These results are consistent with chemical
probing experiments of the SAM-II riboswitch (10). In the
chemical probing experiment, the reactivity of a particular
domain is directly correlated with its ﬂexibility. It was
shown that L1 becomes less reactive upon binding SAM,
suggesting that L1 is ﬂexible in the unbound form of the
riboswitch and localized in the bound form. Distributions
of the ﬁrst two interactions that are made by L1 with the
major groove of P2b in the simulation of the unbound
form of the riboswitch can be separated into a small pop-
ulation that is close to the bound form and a more relaxed
and open ensemble of conformations (Supplementary
Figure S1). More contacts similar to that of the bound
state are formed between U10 and U44 than between
U11 and U21, and more contacts are formed
between U11 and U21 than between U12 and A46
(Supplementary Figure S1). Switching between the diﬀer-
ent conformational states of the riboswitch in the
unbound form is estimated to be very fast and in the nano-
second timescale (Supplementary Figure S2). Therefore,
the limiting step of the on–oﬀ switch will most likely be
the binding and dissociation of SAM that is expected to be
much longer than the nanosecond time scale, based on
binding studies of other riboswitches (60,61).
These results suggest that the unbound form of the
riboswitch periodically forms contacts similar to that of
the bound form that are necessary to stabilize the
ensemble of conformations of the bound form. The
unbound form of the SAM-II riboswitch partially
samples the conformational space of the bound form,
and upon binding of SAM, the classic pseudoknot confor-
mation is fully formed after ‘zipping’ up L1 with the help
of the additional RNA–ligand interactions. The simula-
tion results therefore suggest that the recognition mecha-
nism of the SAM-II riboswitch is due to a combination of
conformational changes of the unbound form to confor-
mations similar to that of the bound form and subsequent
rearrangement of the structure, as exempliﬁed by the
conformational selection (62–64) and induced ﬁt (65)
models of ligand binding, respectively. Interestingly, this
interplay between induced ﬁt and conformational selec-
tion has been previously observed in the guanine-sensing
riboswitch (49).
We have shown that the binding of SAM to the SAM-II
riboswitch localizes L1 in the major groove of the P2b
helix, and our results provide atomistic description of
earlier experimental observation (10) of the ﬂexibility of
L1 in the unbound form. What functional role does L1
have, since it behaves so diﬀerently in the bound and
unbound forms of the SAM-II riboswitch and is a
central feature in stabilizing the classic H-type
pseudoknot? For example, how does the motion of L1
correlate with other parts of the riboswitch? In order to
answer these questions, we have calculated the
cross-correlation coeﬃcients of each residue with all of
the other residues of the SAM-II riboswitch in the
simulation of the unbound form, as shown in Figure 3.
Figure 3 shows the normalized correlation matrix plot of
both positive (red) and negative (blue) correlated motions
1394 Nucleic Acids Research, 2010,Vol.38, No. 4between each residue in the unbound form of the SAM-II
riboswitch. Several positive correlations will naturally
show up between diﬀerent residues, if they are on the
same domain or directly interacting with each other. For
example, the diagonal shows up as positive correlated
motions because it represents the correlation between
each individual residue to itself. However, the interesting
correlated motions are the ones that are long-ranged and
do not involve direct interactions between the residues
in question. For example, in Figure 3 we clearly see
strong negative correlated motions between L1 and the
purine-rich sequence of the expression platform. We also
see correlated motions between binding site residues, espe-
cially residues U21 and G22, and the expression platform.
These results therefore suggest and provide evidence that
binding and dissociation of the ligand, coupled with the
ensuing motions of L1 in and out of the major groove of
the P2b helix, are tied to the motions of the expression
platform. The correlation of the motions between the
binding site residues, L1, and the expression platform is
interesting, because the mechanism of action of the
riboswitch is to control the dynamics and conformational
changes in the expression platform through binding and
dissociation of the ligand.
Ligand-induced curvature and base-pairing of the
expression platform
The expression platform is a key component of bacterial
mRNA structure and directs the ribosome to the proper
location in order to initiate protein synthesis. The ulti-
mate goal of conformational switching in the SAM-II
Figure 2. Distances between N3 of U10 and O4 of U44 (black), O4 of U11 and O4 of U21 (red) and O4 of U12 and N6 of A46 (blue) in the bound
form (left column) and unbound form (right column) of the SAM-II riboswitch during the simulations. The colors are consistent with the corre-
sponding interactions shown in Figure 1B.
Figure 3. Correlated motions of the SAM-II riboswitch calculated
using the simulation of the unbound form. The color bar shows the
relationship between the cross-correlation coeﬃcients and the intensity
of the colors. Red and blue represent strong positive and strong
negative correlations, respectively. The residue numbers of the L1
region of the SAM-II riboswitch that is in the major groove of the
P2a/b helix are highlighted with a green line, and the residue
numbers representing the purine-rich region of the expression
platform are highlighted with an orange line. The positions of the
two residues (U21 and G22) in the binding site, sandwiching the
adenine moiety of SAM in the bound form are shown with arrows.
The region showing correlated motions between L1 and the expression
platform is labeled as (A), and the region showing correlated motions
between the binding site residues and the expression platform is labeled
as (B).
Nucleic Acids Research,2010, Vol.38, No. 4 1395riboswitch is to initiate or terminate translation due to
induced conformational changes in the expression
platform that expose or conceal the ribosomal recognition
sequence. The AUG start codon, which is not part of the
crystal structure, would normally be found downstream,
immediately after the 30-end of the riboswitch. As we have
already seen above, the motions of the binding site, L1
and the expression platform are correlated. A hypothesis
based on occlusion of the recognition SD sequence in
repressing translation was proposed as a result of the
pseudoknot structure of the SAM-II riboswitch and
chemical probing experiments (10). It was assumed that
stabilization of the pseudoknot structure by SAM locks
the expression platform in an ensemble of conformations
that prevent the bases of the recognition sequence from
ultimately interacting with the ribosome. One main obser-
vation of the expression platform in the bound form (as
shown in Figure 1) is that it is an integral part of the
helical structure formed by the P2a/b helix, following
the curvature of the helix, in the bound structure. Since
the metabolite-bound form of the pseudoknot structure of
SAM-II represses translation, it is obvious that this par-
ticular conformation would not allow ribosomal assembly
or translation to proceed. It is therefore assumed that a
diﬀerent ensemble of conformations of the expression
platform would serve as a proper recognition conforma-
tion or a proper conformation to initiate translation. We
have therefore studied the curvature of the expression
platform in the bound and unbound forms of the
riboswitch, as shown in Figure 4. In order to calculate
the eﬀective curvature, we ﬁtted the phosphorus atoms
of six of the last seven phosphate groups to an eﬀective
circle.
Figure 4 shows distributions of the eﬀective curvature
of the expression platform during the entire simulations
with and without the presence of SAM. It can be seen that
the expression platform of the bound form is more curved
and has a narrower distribution than that of the unbound
form of the riboswitch. The bound riboswitch exhibits a
stable, tightly curved binding platform; however, the
unbound riboswitch shows variation in curvature with
an overall unwinding of the platform. The distribution
of the eﬀective curvature of the unbound riboswitch
partly overlaps with that of the bound form, providing
further evidence that the unbound form of the riboswitch
partially samples the conformational space close to that of
the bound form. The results suggest that in the absence of
SAM, the platform uncurls and exposes the binding
platform for possible ribosomal assembly or initiation of
translation. As the binding platform straightens out, the
bases of P2a/b become exposed and readily accessible, as
shown in Figure 5A.
Figure 5 shows the distribution of the interactions
between the three most upstream bases of the purine-rich
sequence (Figures 1 and 5B; orange) on the P2a/b helix
that contains the expression platform on the 30-end and
the bases on the 50-end of the same helix in the bound and
unbound forms of the SAM-riboswitch. It can be seen that
the interactions between these bases and their pairing
partners on the opposite strand, as depicted in the X-ray
crystal structure (Figure 5B), are very stable and well
formed in the ligand bound form of the SAM-II
riboswitch. However, in the unbound form of the
riboswitch, these same interactions are loosely formed
and the distributions are much broader than that of the
bound form. Unlike the P2a/b helix, bases pairing in the
P1 helix are unaﬀected by metabolite binding (Figure 5C),
also in agreement with chemical and inline probing
experiments (10,39). Figure 5C shows distributions of
the interactions between the bases of three base pairs
around the center of the P1 helix in the metabolite-
bound and unbound forms of the SAM-II riboswitch.
The distribution of the base pairing distances in the
unbound form is almost identical to that of the bound
form.
These results therefore suggest pairing of the bases in
the expression platform upon binding of the metabolite,
concealing the bases from direct interaction with cellular
components in the oﬀ state. On the other hand, the bases
are hardly paired in the unbound form, and these loosely
paired bases would be pivotal for the assembly of the
ribosome. Alternatively, the expression platform of the
metabolite-bound pseudoknot structure of the SAM-II
riboswitch could still bind the ribosome, but blocks trans-
lation until after dissociation of the metabolite and the
subsequent conformational changes in the expression
platform. Previously, Marzi et al. (66) reported a series
of cryo-electron microscopy images suggestive of the fact
that folded 50 UTR of mRNAs may still bind the
ribosome, but blocks initiation of translation until
the mRNA unfolds. The simulation results suggest that
the changes in the curvature and base-pairing of the
expression platform partly control the interactions of the
riboswitch with the ribosome.
Fully understanding how such conformational changes
accompany ligand binding and how they direct initiation
or termination of translation (or transcription, as in the
Figure 4. Probability distributions, p( ), of the eﬀective curvature, k,o f
the expression platform in the bound (black) and unbound (red) forms
of the of the SAM-II riboswitch. Ensembles of structures of the bound
state (right inset) with a curved expression platform and unbound state
(left inset) with a less curved expression platform are shown as insets.
The structures represent a 5ns segment of the simulation that matches
the conformations at the peaks of the distributions.
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insight into bacterial gene regulation. The ability to
modulate gene regulation in bacteria holds tremendous
promise in designing new classes of antibiotics. The
metabolite sensing riboswitches have so far only been dis-
covered in prokaryotes, fungi and plants (13,67,68), there-
fore, targeting this gene regulation mechanism as a
therapeutic strategy could potentially have little or no
side-eﬀect to a human host.
CONCLUSIONS
Most of the X-ray crystal structures of riboswitches solved
to date that undergo large conformational changes are in
the metabolite-bound form. Therefore, there is limited
structural information about their unbound states and
the mechanism of the on–oﬀ switch. Our MD simulation
studies have revealed the nature of the ligand-induced
conformational changes of the SAM-II riboswitch at
atomistic detail and agree very well with previous
chemical and inline probing experiments. The classic
H-type pseudoknot structure of the SAM-II riboswitch
is only fully formed in the metabolite-bound structure.
In the unbound structure, the SAM-II riboswitch alter-
nates between a loosely formed pseudoknot structure
and an ensemble of conformations that are close to that
of the bound form. Ligand binding stabilizes L1 in the
major groove of the P2a/b helix, causing the helix to par-
tially wrap around L1 and induces curvature and stabilizes
base-pairing in the expression platform. The loose and
ﬂexible nature of the unbound form of the SAM-II
riboswitch would make it diﬃcult to investigate the
unbound form of riboswitches using X-ray crystal-
lography. However, other experimental techniques, such
as NMR, SAXS and chemical probing, could provide
valuable insight into the nature of the unbound states of
riboswitches. Similarly, theoretical and computational
methods can complement experiments in further under-
standing and providing another perspective of the
switching mechanism of riboswitches in bacterial gene
regulation at atomistic detail, as we have done in these
studies.
Figure 5. Probability distributions of distances, p(r), between the bases of three base-pairs in the purine-rich expression platform of the P2a/b helix.
The distances are measured between N3 of U20 and N1 of A46, N6 of A19 and N3 of A47, and O2 of U18 and N6 of A48 (A) from the simulations
of the bound (black) and unbound (red) forms of the SAM-II riboswitch. The base-pairing interactions are shown in the X-ray crystal structure of
the SAM-II riboswitch (B). Probability distributions of distances, p(r), between the bases of three base-pairs around the center of the P1 helix are also
shown (C). The distances are measured between N1 of G3 and N3 of C29, N3 of C4 and N1 of G28, and N1 of G5 and N3 of C27 from the
simulations of the metabolite bound (black) and unbound (red) forms of the SAM-II riboswitch.
Nucleic Acids Research,2010, Vol.38, No. 4 1397Our simulations show that the rate of sampling the dif-
ferent conformational states of the unbound form of the
SAM-II riboswitch, including conformational states
similar to that of the bound form, is on the nanosecond
timescale. The results therefore suggest that the rate of
dissociation of SAM will determine whether the mecha-
nism of action of the SAM-II riboswitch is thermodynam-
ically or kinetically driven. Since the lifetime of
prokaryotic mRNAs is very short (minutes) (69), design-
ing new drugs that can compete with SAM and bind to the
SAM-II riboswitch with a very slow dissociation rate
would therefore be a good strategy in shutting down the
translational machinery of the SAM-II riboswitch.
Computational methods
MD simulations. The bound crystal structure of the
SAM-II riboswitch (PDB id:2qwy; chain A) solved by
Gilbert et al. (10) was the starting point for all simula-
tions. All MD simulations were carried out using the
Amber 10 suite of programs (70). In order to obtain the
unbound form of the riboswitch, the structure was edited
to remove the ligand. All of the crystallographic water
molecules and ions were preserved. The modiﬁed nucleic
acid parameters (parmbsc0) (71) of the Cornell et al. (72)
Amber force ﬁeld were used. These parameters along with
the structure of the unbound riboswitch were loaded into
the LEAP module in Amber. The system was placed in an
explicit TIP3P (73) truncated octahedron water box con-
sisting of 11257 water molecules, and 50 Na+ counter
ions were added to bring the system to neutrality. After
minimizing the system, a 10ns equilibration was carried
out using the PMEMD module. The Langevin thermostat
was used during the equilibration in order to bring the
system from 100K to 300K using a collision frequency
of 1.0/ps. Following the 10ns equilibration, a 200ns
long MD simulation was carried out. Particle mesh
Ewald (74) method was used to treat long range
electrostatics. A 2 fs time-step was used to solve
Newton’s Equations of Motion at a constant pressure of
1 bar and a constant temperature of 300K using the NTP
ensemble. All bonds involving hydrogen atoms were
restrained using the SHAKE algorithm (75), and a 9A ˚
cutoﬀ was applied to all long ranged non-bonded
interactions.
Starting with the SAM ligand previously removed from
the crystal structure of the riboswitch, the GaussView
program (76) was used to add hydrogens to the ligand
and the structure was quantum mechanically optimized
using the Gaussian program at the HF/6-31-g(d) level of
theory. Force ﬁeld parameters were obtained using the
Antechamber module in Amber, and partial charges
were generated with the RESP (77) method from the
electrostatic potential calculated using the Gaussian
program, also at the HF/6-31g(d) level of theory. These
force ﬁeld parameters and charges were loaded into LEAP
along with the default nucleic acid parameters in order to
prepare the SAM-II riboswitch complex. The complex was
also solvated in a truncated octahedron TIP3P water box
consisting of 11254 water molecules. The positive charge
of the ligand resulted in the addition of only 49 Na+
counter ions to the system in order to bring it to neutral-
ity. Equilibration and dynamics were carried out from this
point on under the same conditions and for the same
length of time (200ns) as for the free riboswitch.
Cross-correlation coeﬃcients. The residue–residue
cross-correlation coeﬃcients were calculated using the
trajectories of the entire simulation of the unbound form
of the SAM-II riboswitch. The cross-correlation coeﬃ-
cient Cij ¼ < rirj >=ð< r2
i >< r2
j >Þ
1=2 for the dis-
placement of any two atoms i and j, where ri is the
displacement from the average position of i. The
cross-correlation coeﬃcients, Cij, is therefore a 2D
matrix with the value of each coeﬃcient between +1.0
and  1.0, where +1.0 signiﬁes perfect positive correlated
motions, and  1.0 signiﬁes perfect negative correlated
motions. The cross-correlation coeﬃcients were averaged
over each residue, such that there was only one Cij per
residue. The cross-correlation coeﬃcients are then
plotted using a color-coded 2D matrix from red (+1) to
blue ( 1).
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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